EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Amino acid and protein Sources: 5

Carnosine (L-carnosine)

Also called: L-carnosine, beta-alanyl-L-histidine

L-carnosine (β-alanyl-L-histidine) is a naturally occurring dipeptide of β-alanine and L-histidine, found mainly in tissues with high metabolic demand such as skeletal muscle and the central nervous system. Trials have tested L-carnosine alone and combined with anserine.

Category
Amino acid and protein
Forms
L-carnosine (oral); zinc-L-carnosine is another form; some trials combine L-carnosine with anserine
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 2 Moderately studied in people. A 2021 systematic review of L-carnosine in children with autism spectrum disorder included 4 double-blind, placebo-controlled RCTs and 1 open-label trial (215 participants in total). Other reviews mix L-carnosine trials with trials of carnosine combined with anserine or other compounds. [2]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Carnosine (L-carnosine) does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Carnosine (L-carnosine), evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood glucose and lipidsBA 2020 meta-analysis of 4 RCTs (184 participants) found lower HbA1c (-0.92%) with carnosine but no significant change in fasting blood sugar, HOMA-IR, cholesterol, triglycerides or HDL-C. [3]
Cognitive functionCIn a 2026 review, five RCTs found no significant differences between L-carnosine and placebo on most cognitive measures; pooled benefits came from carnosine combined with anserine or antioxidants, with low strength of evidence. [1]
Autism spectrum disorder in childrenCA 2021 meta-analysis of 3 placebo-controlled studies found no significant difference in autism rating scales (GARS, CARS); the authors say current data do not support its use. [2]
Inflammation and oxidative stress markersCA 2024 meta-analysis of 9 trials (350 participants) of carnosine or other histidine-containing dipeptides found lower CRP, TNF-α and MDA but no effect on IL-6, adiponectin, GSH, SOD or TAC. [4]

Main constituents: L-carnosine (β-alanyl-L-histidine), a histidine-containing dipeptide [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Across studies in a 2026 review, L-carnosine doses ranged from 100 to 2,000 mg/day for 6 weeks to 12 months. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    2 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • Only 34% of the RCTs in a 2026 review reported adverse events, including constipation, drowsiness and dizziness, nausea, dry mouth, appetite change, elevated liver enzymes, paresthesia and stiffness. [1]
  • The original trial authors reported no significant difference in adverse-effect frequency between intervention and control groups, or reported that the effects were not related to the intervention. [1]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [5]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • L-carnosine (β-alanyl-L-histidine), a dipeptide of β-alanine and L-histidine Amino acids, amines and peptides (dipeptide) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 2 entries naming carnosine, both as zinc carnosine (earliest NDI 158 submitted 2002-05-14; most recent NDI 799 submitted 2013-06-14). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of carnosine was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-30). [P3]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no study of carnosine (checked 2026-10-30). [P4]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P5]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • After intestinal absorption through the peptide transporter PEPT1, L-carnosine is rapidly hydrolyzed in the bloodstream by serum carnosinase (CN1) into β-alanine and L-histidine; anserine is resistant to this breakdown. [P1]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Hsiao YF, et al. The Effects of Carnosine on Cognitive Function and Mental Health: A Systematic Review and Meta-Analysis. Nutrients 2026;18(9):1385 (PMID 42123986; full text PMC13165363), 2026-04-28. pubmed.ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142, 2026-10-30. monographs.iarc.who.int
  4. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-30. ntp.niehs.nih.gov
  5. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/29/2026), 2026-10-29. ecfr.gov
Sources

Sources

  1. Hsiao YF, et al. The Effects of Carnosine on Cognitive Function and Mental Health: A Systematic Review and Meta-Analysis. Nutrients 2026;18(9):1385 (PMID 42123986; full text PMC13165363), 2026-04-28. pubmed.ncbi.nlm.nih.gov
  2. Abraham DA, et al. Effect of L-Carnosine in children with autism spectrum disorders: a systematic review and meta-analysis of randomised controlled trials. Amino Acids 2021;53(4):575-585 (PMID 33704575), 2021-03-11. pubmed.ncbi.nlm.nih.gov
  3. Peng W, et al. Effect of carnosine supplementation on lipid profile, fasting blood glucose, HbA1C and insulin resistance: a systematic review and meta-analysis of long-term randomized controlled trials. Complement Ther Med 2020;48:102241 (PMID 31987255), 2019-11-14. pubmed.ncbi.nlm.nih.gov
  4. Saadati S, et al. Effects of carnosine and histidine-containing dipeptides on biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis. Nutr Rev 2024;82(12):1696-1709 (PMID 38086332), 2024-12-01. pubmed.ncbi.nlm.nih.gov
  5. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Collagen peptides · Creatine · Glutathione · L-arginine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.